CSL’s profits have taken a hit from Americans’ reluctance to get vaccinated,sending its shares downward.
This week’s ASX Bulls N’ Bears Runner of the Week is… Bio-Gene Technology. The company’s shares leapt after revealing it scored a slice of two US defence grants.
If you thought crypto investors need to have strong stomachs,spare a thought for the investors who try their luck in the biotech sector.
This week’s Bulls N’ Bears Runner of the Week is … Hydration Pharmaceuticals. The company sold its non-US assets for a sum five times its market capitalisation.
Danish drugmaker Novo Nordisk has eclipsed French luxury group LVMH to become Europe’s most valuable company – thanks to demand for diabetes and weight-loss drugs.
Biomedical engineer Daniel Timms lost his father to heart disease,but their kitchen-top tests helped him hone a radical idea.
The Aus-designed artificial heart set to revolutionise medicine| Preppers go mainstream| A sperm donor’s message to his progeny
Australian researchers are responsible for a series of globally significant medical inventions and innovations.
The future of a government funding program which has assisted teams developing artificial hearts and turning spider venom into drug therapies is in doubt.
Australia will spend $50 million building the world’s first long-term artificial heart,after the original prototype was built with pieces bought from Bunnings.